Richard Slayman, quien fue el primer paciente vivo en recibir un trasplante de riñón de cerdo modificado genéticamente, falleció en Estados Unidos. Slayman fue sometido a este tratamiento inédito en marzo de este año. No se considera que la intervención haya sido la razón de su muerte. (Video: América TV)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZJRMYQTLGVFTTCQZDWD6JUNJ34.png)
:quality(75)/cdn.jwplayer.com/v2/media/aX7MqUY3/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/D7RUNTRXYJFG5LQLJPDA4W4BNM.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6RGtWpJf/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FKA4XFHLCRHFRLXOD7VUBCVZT4.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/mZOvs1Mf/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/yjHFgnG8/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/P0kM2Q88/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/4K5U7ffR/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ZJRMYQTLGVFTTCQZDWD6JUNJ34.png)
:quality(75)/cdn.jwplayer.com/v2/media/vALdeDXW/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/NCusFWKV/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ZnwetseC/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/D7RUNTRXYJFG5LQLJPDA4W4BNM.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6RGtWpJf/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6VP1RTTH/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/pt4bGlfx/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FKA4XFHLCRHFRLXOD7VUBCVZT4.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/bUfOudTg/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/3vrkEqPP/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FJ7Q5JKFFRE27A5K3HSMTAQPT4.png)
:quality(75)/cdn.jwplayer.com/v2/media/koNs9MA2/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/6bLTGi5d/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/KgeU8b6Q/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/a6mwPQ4X/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/TKKX4BWRSJGLXHJNZFN44U6N4M.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/X3PAJUVAAFHRXHUYV5TON7UAAY.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/N77VMFVWS5HU3BXDR3L5EOC76U.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/IAG34YYV3FG6ZA6ZBPBY637KTE.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/OzNVbTsL/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/c0S03whF/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/azLadx4o/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/FQ5XSTUGQ5DI3DYDC3MUSLQL6A.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/dXst1BW1/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/QYPNFGK56RE7FB6OYBZFBZOR6M.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/8j1uxDqb/poster.jpg)
:quality(75)/cdn.jwplayer.com/v2/media/ZxUTUGfS/poster.jpg)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/JW2JBE7IBZEY5NR2VH4KVTPGZ4.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/42WZKDIDGVA6VKQDF75376W2CA.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/ENCJ6JEIFZHT5E6UXK3KZ5RCUU.png)
:quality(75)/cloudfront-us-east-1.images.arcpublishing.com/elcomercio/UZ27WLDNBFBCPCMLG42DQCNJYA.png)